Important Shipping Restriction: We are currently unable to ship to Rhode Island, Pennsylvania, Maryland, New Jersey, or New York. If your shipping address is in one of these states, please do not place an order at this time. Syphilis Screening | At-Home Collection Kit Screen for Treponema pallidum, the bacterium that causes syphilis, using a home collection sample processed in our CLIA-certified molecular laboratory. Early detection through regular screening supports timely follow-up care. Pathogen screened: Treponema pallidum (Syphilis) Sample type: Capillary blood by painless shoulder collection. What's included: Alcohol Prep Pad · Shoulder Lancet · Heat Pack to encourage Vasodilation · Microtainer for Small Quantity Blood Collection · Small Adhesive Bandage · Free shipping · Prepaid return shipping Included · Label for Collection Tube · Reminder Card · Clinician-authorized test order · Secure online results How it works: Purchase your kit Register online — a licensed clinician reviews and authorizes your order Collect your blood sample following the included instructions Ship your sample in the pre-paid mailer Receive your results securely online About your results timeline: Average TAT for 2026 is currently ~18 hours once we receive your sample. Samples received on Friday may take up to 4 days for processing as we do not test on the weekend. The most common reason a sample fails to arrive at our facility is that we primarily use UPS, so please make sure to drop it off at a UPS pickup location, and not at the local post office unless otherwise indicated! About our laboratory: CLIA-certified · California License CLF-90008896 · CLIA ID# 05D2278233 Laboratory Developed Test (LDT): This test was designed, validated, and is performed exclusively at Genome-Based Diagnostics' CLIA-compliant high complexity laboratory (CLIA ID# 05D2278233). LDTs are tests developed and used within a single certified laboratory rather than manufactured for distribution. This test has not undergone FDA premarket review, and its performance characteristics were determined by Genome-Based Diagnostics, meeting or exceeding all applicable CLIA LDT requirements. This is a laboratory screening test processed in our CLIA-compliant facility. A positive screening result should be confirmed by a licensed healthcare provider. Results are not a substitute for clinical evaluation or medical advice.
Related
Related
Related
Related